Professional Background:
Since completing a PhD in UK at Cambridge University, and starting my career with Cambridge Antibody Technology (Medimmune, UK) to my current role at Telix Pharmaceuticals, I have been fortunate to have worked in a number of technical or research roles with biotechnology industry leaders in precision medicine. I have also worked in senior development roles at a number of successful smaller companies including Medicines Development Limited, Hatchtech and Starpharma Limited; performing activities related to GMP clinical manufacture, clinical study support and nonclinical studies and research for a range of pharmaceutical and medical device products.
Research Interests:
I oversee a research team involved in the development of novel theranostics (including biologics, engineered antibodies, bioconjugates, peptides and small molecules) and researching the role of targeted radiation to address unmet needs in oncology. This covers a broad number of topics from identifying new cancer targets/targeting agents, optimisation of radiobiologic outcomes, evaluating the impact of drug combinations on tumour biology / immuno-oncology, developing radiation-/fluorescent-guided surgical technologies and exploring novel radioisotope chelators & payloads. I am inspired by the potential of combining the innovative ideas from academia with the resources & knowledge of drug development from industry to develop new drugs that benefit patients.
